AAMA
BIIB icon

Advanced Asset Management Advisors’s Biogen BIIB Stock Holding History

Advanced Asset Management Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-6,700
Closed -$1.58M – 90
2019
Q1 		$1.58M Hold
6,700
– – 0.57% 48
2018
Q4 		$2.02M Hold
6,700
– – 0.65% 40
2018
Q3 		$2.37M Hold
6,700
– – 0.86% 20
2018
Q2 		$1.95M Hold
6,700
– – 0.63% 33
2018
Q1 		$1.83M Hold
6,700
– – 0.61% 36
2017
Q4 		$2.13M Buy
+6,700
New +$2.15M 0.7% 28

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Advanced Asset Management Advisors's BIIB Position: Q2 2019 in Review

Advanced Asset Management Advisors sold out of Biogen (BIIB) in Q2 2019, closing a stake of 6,700 shares — an estimated $1.58M sold.

Advanced Asset Management Advisors first reported a position in BIIB in Q4 2017 and held it in 6 quarters. The position peaked at $2.37M in Q3 2018. 1,010 funds tracked by Wall St. Rank hold BIIB as of Q2 2019.

  • Advanced Asset Management Advisors reported no remaining Biogen position as of Q2 2019 after selling out during the quarter.
  • Advanced Asset Management Advisors sold 6,700 Biogen shares in Q2 2019, an estimated $1.58M.
  • Advanced Asset Management Advisors first reported a position in Biogen in Q4 2017 and held it in 6 quarters.
  • Advanced Asset Management Advisors's Biogen position peaked at $2.37M in Q3 2018.
  • 1,010 funds tracked by Wall St. Rank held Biogen as of Q2 2019.

Based on Advanced Asset Management Advisors's 13F filing for Q2 2019, filed 2 Aug 2019.